Clinical Trials

Title   [865524-3] A Multi-Center, Open-Label, Study to Evaluate the Safety and Efficacy of Ublituximab (TG-1101) in Combination with TGR-1202 for Patients Previously Enrolled in Protocol UTX-TGR-304
Description   This is a multi-center, open-label, study to evaluate the safety and efficacy of ublituximab (TG-1101) in combination with TGR-1202 for patients who have progressed on treatment arms previously enrolled in Protocol UTX-TGR-304
IRB Number   16-064
Treatment   Oncology - Leukemia
Status   Active
Principal Name   David Clarkson, M.D.
Contact Name   Kathleen Ollis

Email Newsletters

Connect With Us